Skip to main content
Clinical Trials/ISRCTN13076797
ISRCTN13076797Completed未知

Development and evaluation of an intervention to support Adherence to treatment in adults with cystic fibrosis: A feasibility study comprised of an external pilot randomised controlled trial and process evaluation (WP 3.1)

Sheffield Teaching Hospitals NHS Foundation Trust0 sites61 target enrollmentStarted: June 7, 2016Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
61

Study Overview

Brief Summary

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29886416 results (added 08/05/2019) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32697197/ results (added 24/07/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34665573/ (added 10/07/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33109661/ (added 10/07/2023) 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/30975206/ (added 10/07/2023)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Diagnosed with CF and within CF registry
  • 2. Aged 16 years and above
  • 3. Taking inhaled mucolytics or antibiotics via a chipped nebuliser (e.g. eTrack or I-Neb or able and willing to take via eTrack or I-Neb)

Exclusion Criteria

  • 1. Post-lung transplant
  • 2. People on the active lung transplant list
  • 3. Patients receiving palliative care, with palliative intent, for whom trial participation could be a burden
  • 4. Participants who lack capacity to give informed consent 5) Participants using dry powder devices to take antibiotics or mucolytics

Investigators

Similar Trials

Adherence to treatment in adults with... | Clinical Trial